Screener
Innoviva, Inc. INVA Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 72.2%-10.9pp | 73.7%-9.9pp | 74.8%-7.8pp | 79.8%+0.6pp | 83.1%+2.0pp | |
| Operating margin | 36.9%-10.7pp | 38.1%-11.2pp | 39.8%-6.7pp | 43.2%+0.1pp | 47.7%+6.1pp | |
| Net margin | 81.2%+70.8pp | 119.9%+136pp | 65.9%+59.4pp | 32.8%+14.5pp | 10.4%-33.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 16×+13.4× | 21.1×+18.7× | 14.6×+12.3× | 14.1×+12.3× | 2.6×-10.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×— | 0.2×— | 0.2×-0.4× | —— | —— | |
| Net debt / EBITDA | -1.6×-1.9× | -1.8×-2.4× | -1.5×-2.2× | -1.1×-2.2× | 0.3×-1.2× | |
| Per Share | ||||||
| Book value per share | $16.80— | $15.81— | $13.84+48.5% | —— | —— | |
| Valuation | ||||||
| Market capitalization | $1.53B+33.1% | $1.73B+51.8% | $1.49B+37.6% | $1.15B-4.8% | $1.3B+26.8% | |
| Price / earnings | 4.3×-25.4× | 3.4×— | 5.5×-40.9× | 9×-9.7× | 33.6×+26.5× | |
| Price / sales | 3.5×+0.4× | 4.1×+1.0× | 3.6×+0.6× | 3×-0.5× | 3.5×+0.4× | |
| Price / book | 1.2×— | 1.3×— | 1.3×-0.3× | —— | —— | |
| EV / EBITDA | 6.5×+0.6× | 7.5×+1.4× | 6.4×0.0× | 4.8×-3.0× | 6.7×-1.0× |
FAQ
- What are Innoviva, Inc.'s profit margins?
- Innoviva, Inc. (INVA) runs a 72.2% gross margin and a 36.9% operating margin, with a 81.2% net margin.
- Where do Innoviva, Inc.'s ratios come from?
- Every ratio is computed from Innoviva, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
